News and Events
Johnston County Votes to Support New Expansion for Novo Nordisk
Danis Pharmaceutical Leader to Invest $65 Million in Existing Diabetes Finished Product Manufacturing Facility
Novo Nordisk, the world’s leading diabetes care company, will embark on a $65 million expansion at its Clayton campus, its third there since 2010.
Headquartered in Denmark, the pharmaceutical company currently employs over 1,000 manufacturing workers in Johnston County and is likely to hire almost two dozen additional
employees to staff its growing Diabetes Finished Products Facility (DFPF), which is responsible for the formulation, filling, inspection, assembly and packaging of diabetes
and obesity medicines.
Grifols to Launch $210 Million Expansion in Clayton
Creating 250 Jobs
For the second time in less than eight months, a global
bio-manufacturing company has chosen Johnston County for a significant expansion.
Earlier today, the Johnston County Board of Commissioners approved a 10-year
incentive package that paves the way for Grifols Therapeutics Inc. to launch a
$210 million expansion at its facility near Clayton. The Spain-based leader in
plasma-derived medicine, already the county’s largest private employer, will create
250 new jobs here over the coming decade.
"Our county is proud to take its partnership with this
leading biotech company to an exciting new level," said Tony Braswell,
chairman of Johnston County’s Board of Commissioners, who presided over
today’s unanimous vote. As Grifols meets its projections on capital
investment and job creation, the county will grant up to $1,277,640 annually to the
company for 10 years. “Economic development, when it takes place at this level,
is all about partnerships, and it is crucial that the county be a good partner.
That means being prepared to share part of the risks as well as the rewards that
will grow from this."
Novo Nordisk To Add Major New Bio-Manufacturing Operations In Clayton
$1.2 billion economic investment will add 691 employees
Johnston County will be the beneficiary of a $1.2 billion economic investment by Novo Nordisk Pharmaceutical Industries, Inc., as the Danish company launches new operations at its Clayton campus to manufacture the active ingredient for its insulin products. Novo Nordisk’s decision, approved earlier today by its board of directors, brings an additional 691 bio-manufacturing jobs to the county.
“This billion-dollar decision by Novo Nordisk more than doubles the size of its North Carolina workforce and underscores the Research Triangle’s global leadership in bio-manufacturing,” said Governor McCrory. “When it comes to life sciences and manufacturing, North Carolina can compete – and win – against any location in the world.”
Industry Appreciation Award
COMMISSIONERS HONOR JCI WITH INDUSTRY APPRECIATION AWARD
Johnston County, N.C. – November 6, 2017. The Johnston County Board of Commissioners honored officials of JCI, Inc., today with the county’s Industry Appreciation Award. The citation was given to the not-for-profit company at the Board’s regular meeting in Smithfield this morning.
“Here’s an organization that has helped countless people across five counties build and maintain strong connections to the job market, all the while offering companies in the region access to a wide array of necessary skill-sets,” said Jeffrey Carver, chairman of the Board of Commissioners. “JCI serves a mission that benefits both the public and private sectors, and helps keep the fabric of our community and local economy strong.”
PENN COMPRESSION LAUNCHES $3 MILLION EXPANSION, CREATING 40 JOBS
Penn Compression Molding, Inc., a national manufacturer of custom molding thermoset composites,
will expand its Smithfield operations to include another 30,000 square feet of production space. The company's $3 million expansion
will result in the addition of 40 new jobs for Johnston County.